Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Aslan Pharma Plans $40 Million Taiwan IPO in May | April 12, 2017
BGI Genomics Re-Files to Raise $250 Million in Shenzhen IPO | March 15, 2017
Ally Bridge Backs $301 Million Privatization of Luoxin Pharma | March 15, 2017
Fosun Pharma May Enter $4 Billion Bidding War for Germany's Stada | March 10, 2017>> See all top stories...
ChinaBio® in the News